Researchers introduce a framework for evaluating biological capabilities and risks of AI agent systems capable of autonomous scientific research. The paper synthesizes evidence on AI-enabled biological risks and provides practical guidance for policymakers, funders, and biosecurity practitioners to interpret evaluation results with appropriate caution, highlighting how methodological design choices significantly shape what conclusions can be drawn about risk.
The emergence of agentic AI systems—autonomous agents capable of conducting multi-step scientific research—creates a critical evaluation gap for policymakers and security practitioners. This arXiv paper addresses how to credibly assess both the capabilities and biosecurity risks posed by these systems as they integrate into legitimate research workflows. The fundamental challenge is methodological: evaluation results depend heavily on implicit design choices that often lack clear documentation, making it difficult for decision-makers to interpret what results actually mean about real-world risk.
The research builds on growing concern about dual-use biological capabilities in frontier AI systems. As large language models and specialized AI agents become more capable at scientific reasoning and experimental design, the potential for misuse in dangerous biological research has accelerated from theoretical to practical concern. This paper synthesizes existing evidence on AI-enabled biological risks and establishes biological agentic evaluations as a methodologically sound but interpretation-sensitive assessment tool.
The practical impact extends across multiple stakeholders. Policymakers gain a framework for making informed regulatory decisions about AI-biology integration. Public and private funders can identify high-leverage investment areas in evaluation research infrastructure. Biosecurity practitioners obtain guidance for assessing emerging systems against organizational risk thresholds. The secondary audience—researchers in frontier labs and third-party evaluators—gains methodological clarity that should improve consistency and credibility of future evaluations.
Looking ahead, the critical development is whether industry, academia, and policy communities adopt these evaluation standards. Without standardized, well-documented assessment frameworks, regulators will struggle to make evidence-based decisions about deploying advanced AI in sensitive research domains.
- →Evaluation methodology design choices materially shape conclusions about AI biological risks, requiring transparent documentation and standardized frameworks
- →Agentic AI systems performing multi-step scientific tasks represent an emerging biosecurity concern requiring credible assessment tools
- →Current evaluation approaches lack consistency in definitions, design, scoring, and documentation across different labs and organizations
- →Policymakers and funders need guidance interpreting biological evaluation outputs to make informed decisions about AI deployment in research
- →Standardized evaluation frameworks could improve risk assessment consistency across frontier labs, AI providers, and scientific institutions